Isolation of Immune Cells for CAR-T Cell Therapy Manufacturing
The rapidly growing Cell Isolation Market plays a crucial role in advancing CAR-T cell therapies, which require precise isolation of immune cells from patient blood samples. Isolation of T cells and other immune subsets is essential for engineering these cells to recognize and attack cancer targets effectively.
Technologies such as magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS) enable high-purity separation of immune cells with preserved functionality. Optimizing cell isolation ensures robust CAR-T cell manufacturing with improved therapeutic efficacy. With increasing demand for personalized immunotherapies, scalable and clinically compliant cell isolation methods are vital.
3 Views